Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

AGM Statement

20 Mar 2019 07:00

RNS Number : 3317T
Arden Partners plc
20 March 2019
 

Arden Partners plc

("Arden" or the "Company")

 

Annual General Meeting Statement 2019

 

 Arden Partners plc (AIM: ARDN), the institutional stockbroking company, will hold its Annual General Meeting ("AGM") at 12.30 pm today at 125 Old Broad Street, London EC2N 1AR.

 

The following statement will be made at the AGM:

 

"As predicted in the 2018 Annual Report, market conditions have remained challenging and we expect them to continue to be so in the short term.

 

Nevertheless, in the year to date we have completed a number of fundraisings and advisory transactions on behalf of our corporate clients.

 

Furthermore, we have continued to grow our corporate client base which remains key to our strategy.

 

The Company's balance sheet remains strong and despite the market challenges we have a good pipeline of corporate business."

 

For further enquiries:

 

Arden Partners plc

020 7614 5900

Donald Brown - Chief Executive Officer

James Reed-Daunter - Executive Director

Steve Douglas - Group Finance Director

 

GCA Altium Limited

020 7484 4040

Sam Fuller / Tim Richardson

 

 

Notes for editors

 

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

 

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

 

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

 

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

 

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

 

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

 

The recently added Arden Wealth Management team offers a bespoke discretionary service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUKVURKVAOAAR
Date   Source Headline
4th Jun 201912:40 pmRNSForm 8.5 (EPT/NON-RI)
24th May 201911:55 amRNSForm 8.5 (EPT/NON-RI)
13th May 201910:56 amRNSDirector/PDMR Shareholding
12th Apr 201910:12 amRNSDirector/PDMR Shareholding
20th Mar 20194:34 pmRNSResult of AGM
20th Mar 20197:00 amRNSAGM Statement
13th Mar 20198:58 amRNSDirector/PDMR Shareholding
12th Feb 20191:37 pmRNSDirector/PDMR Shareholding
12th Feb 20191:33 pmRNSBlock Listing Six Monthly Return
6th Feb 20192:22 pmRNSPosting of Accounts and Notice of AGM
29th Jan 20199:15 amRNSDirector/PDMR Shareholding
24th Jan 20197:00 amRNSAudited Results for the Year Ended 31 October 2018
14th Jan 20191:52 pmRNSDirector/PDMR Shareholding
14th Jan 20197:00 amRNSLaunch of Arden Wealth Management
11th Jan 201911:56 amRNSConfirmation of Board Appointment
4th Jan 201911:13 amRNSConfirmation of Board appointment
12th Dec 20182:07 pmRNSDirector/PDMR Shareholding
15th Nov 201811:07 amRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSBoard Appointments
31st Oct 20184:50 pmRNSTotal Voting Rights
29th Oct 201810:10 amRNSTransaction in Own Shares
26th Oct 20187:00 amRNSTransaction in Own Shares
22nd Oct 201812:46 pmRNSDirector/PDMR Shareholding
10th Oct 201811:50 amRNSForm 8.5 (EPT/NON-RI)
10th Oct 201810:03 amRNSForm 8.5 (EPT/NON-RI) (amended)
28th Sep 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th Sep 20183:59 pmRNSDirector/PDMR Shareholding
14th Aug 20188:52 amRNSBlock Listing Six Monthly Return
30th Jul 20187:00 amRNSInterim Results - Six Months Ended 30 April 2018
24th May 20187:00 amRNSBoard Change
18th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
16th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
15th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
14th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
11th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
10th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
9th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
8th May 20181:22 pmRNSForm 8.5 (EPT/NON-RI)
4th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
3rd May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
2nd May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
1st May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
27th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
26th Apr 201812:54 pmRNSForm 8.5 (EPT/NON-RI)
18th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
13th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.